Shanghai Haohai Biological Technology Co., Ltd. Class H (HK:6826) has released an update.
Shanghai Haohai Biological Technology Co., Ltd. announced successful shareholder meetings where all proposed resolutions, including the 2024 Interim Profit Distribution Plan, were passed by a significant majority. The meetings saw strong shareholder participation with over 66% of voting shares represented at the EGM and majorities of over 76% and 17% for A and H Shares respectively in their class meetings. The company confirmed the approval of amendments to management rules for related party transactions and external guarantees, which received near-unanimous support.
For further insights into HK:6826 stock, check out TipRanks’ Stock Analysis page.
